Marva Seifert

923 total citations
37 papers, 542 citations indexed

About

Marva Seifert is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Marva Seifert has authored 37 papers receiving a total of 542 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Infectious Diseases, 24 papers in Epidemiology and 8 papers in Surgery. Recurrent topics in Marva Seifert's work include Tuberculosis Research and Epidemiology (26 papers), Mycobacterium research and diagnosis (19 papers) and Pneumonia and Respiratory Infections (7 papers). Marva Seifert is often cited by papers focused on Tuberculosis Research and Epidemiology (26 papers), Mycobacterium research and diagnosis (19 papers) and Pneumonia and Respiratory Infections (7 papers). Marva Seifert collaborates with scholars based in United States, Switzerland and India. Marva Seifert's co-authors include Timothy C. Rodwell, Donald G. Catanzaro, Antonino Catanzaro, Sophia B. Georghiou, Camilla Rodrigues, Kathleen Moser, Valeriu Crudu, Rebecca E. Colman, Richard S. Garfein and Anita Suresh and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and Scientific Reports.

In The Last Decade

Marva Seifert

32 papers receiving 532 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marva Seifert United States	12	460	380	155	131	54	37	542
Thi Van Anh Nguyen Vietnam	10	481 1.0×	381 1.0×	163 1.1×	147 1.1×	34 0.6×	22	565
Maria Tarcela Gler United States	9	462 1.0×	370 1.0×	181 1.2×	70 0.5×	29 0.5×	15	531
Navisha Dookie South Africa	9	316 0.7×	249 0.7×	102 0.7×	110 0.8×	31 0.6×	13	409
Griselda Tudó Spain	18	481 1.0×	504 1.3×	199 1.3×	146 1.1×	55 1.0×	42	653
Kinuyo Chikamatsu Japan	14	489 1.1×	475 1.3×	193 1.2×	82 0.6×	31 0.6×	54	636
Akio Aono Japan	17	532 1.2×	543 1.4×	192 1.2×	113 0.9×	32 0.6×	71	708
K. Fissette Belgium	15	647 1.4×	667 1.8×	232 1.5×	104 0.8×	69 1.3×	27	762
Zaza Avaliani Georgia	13	455 1.0×	352 0.9×	223 1.4×	89 0.7×	34 0.6×	47	576
S. M. Mostofa Kamal Bangladesh	12	329 0.7×	268 0.7×	114 0.7×	77 0.6×	26 0.5×	23	402
Ernesto Montoro Cuba	9	305 0.7×	281 0.7×	93 0.6×	62 0.5×	35 0.6×	26	382

Countries citing papers authored by Marva Seifert

Since Specialization

Citations

This map shows the geographic impact of Marva Seifert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marva Seifert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marva Seifert more than expected).

Fields of papers citing papers by Marva Seifert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marva Seifert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marva Seifert. The network helps show where Marva Seifert may publish in the future.

Co-authorship network of co-authors of Marva Seifert

This figure shows the co-authorship network connecting the top 25 collaborators of Marva Seifert. A scholar is included among the top collaborators of Marva Seifert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marva Seifert. Marva Seifert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Georghiou, Sophia B., Nestani Tukvadze, Camilla Rodrigues, et al.. (2025). Targeted next-generation sequencing for drug-resistant tuberculosis diagnosis: implementation considerations for bacterial load, regimen selection and diagnostic algorithm placement. BMJ Global Health. 10(11). e019135–e019135. 1 indexed citations

Carpi, Giovanna, Marva Seifert, Swapna Uplekar, et al.. (2025). Comparative assessment of line probe assays and targeted next-generation sequencing in drug-resistant tuberculosis diagnosis. EBioMedicine. 119. 105875–105875. 1 indexed citations

Felner, Jennifer K., et al.. (2025). Multi-level barriers and facilitators to implementing tobacco screening and cessation counseling in a Federally Qualified Health Center. BMC Health Services Research. 25(1). 1457–1457.

Cain, Kelli L., et al.. (2025). Understanding adaptations in a community-vetted COVID-19 testing program. Frontiers in Health Services. 5. 1408940–1408940.

Colman, Rebecca E., Marva Seifert, Sophia B. Georghiou, et al.. (2024). Evaluating culture-free targeted next-generation sequencing for diagnosing drug-resistant tuberculosis: a multicentre clinical study of two end-to-end commercial workflows. The Lancet Infectious Diseases. 25(3). 325–334. 13 indexed citations

Seifert, Marva, Donald G. Catanzaro, Sabira Tahseen, et al.. (2024). Prospective Exploratory Evaluation of Cepheid Xpert Mycobacterium tuberculosis Host Response Cartridge: A Focus on Adolescents and Young Adults. Clinical Infectious Diseases. 80(1). 180–188. 1 indexed citations

Stadnick, Nicole A., Louise C. Laurent, Kelli L. Cain, et al.. (2023). Community-engaged optimization of COVID-19 rapid evaluation and testing experiences: roll-out implementation optimization trial. Implementation Science. 18(1). 46–46. 4 indexed citations

Rabin, Borsika A., Kelli L. Cain, Paul Watson, et al.. (2023). Scaling and sustaining COVID-19 vaccination through meaningful community engagement and care coordination for underserved communities: hybrid type 3 effectiveness-implementation sequential multiple assignment randomized trial. Implementation Science. 18(1). 28–28. 8 indexed citations

Laurent, Louise C., et al.. (2023). Factors associated with COVID-19 vaccine uptake in a US/Mexico border community: demographics, previous influenza vaccination, and trusted sources of health information. Frontiers in Public Health. 11. 1163617–1163617. 7 indexed citations

10.

Órfão, Nathália Hálax, Rúbia Laine de Paula Andrade, Antônio Ruffino-Netto, et al.. (2023). Influence of COVID-19 on the notification of drug-resistant pulmonary tuberculosis cases. BMC Infectious Diseases. 23(1). 497–497. 6 indexed citations

11.

Colman, Rebecca E., Marva Seifert, Donald G. Catanzaro, et al.. (2022). Detecting rifampin and isoniazid resistance in Mycobacterium tuberculosis direct from patient sputum using an automated integrated system. Journal of Clinical Tuberculosis and Other Mycobacterial Diseases. 27. 100304–100304. 3 indexed citations

12.

Seifert, Marva, Donald G. Catanzaro, Rebecca E. Colman, et al.. (2021). Rapid Detection of Extensively Drug-Resistant Tuberculosis in Clinical Samples Using a Novel Tabletop Platform: Protocol for a Prospective Clinical Study. JMIR Research Protocols. 10(7). e26748–e26748. 2 indexed citations

13.

Seifert, Marva, Eva Vargas, Víctor Ruiz‐Valdepeñas Montiel, et al.. (2021). Detection and quantification of Mycobacterium tuberculosis antigen CFP10 in serum and urine for the rapid diagnosis of active tuberculosis disease. Scientific Reports. 11(1). 19193–19193. 13 indexed citations

14.

Crain, Chad, Judith Owiti, Brett Austin, et al.. (2021). Application of ddPCR for detection of Enterococcus spp. in coastal water quality monitoring. Journal of Microbiological Methods. 184. 106206–106206. 4 indexed citations

15.

Seifert, Marva, et al.. (2021). Age and sex distribution of Mycobacterium tuberculosis infection and rifampicin resistance in Myanmar as detected by Xpert MTB/RIF. BMC Infectious Diseases. 21(1). 781–781. 9 indexed citations

16.

Sng, Li‐Hwei, et al.. (2020). The effect of sodium thiosulfate on the recovery of Mycobacterium chimaera from heater–cooler unit water samples. Journal of Hospital Infection. 105(2). 252–257.

17.

Colman, Rebecca E., Aurélien Macé, Marva Seifert, et al.. (2019). Whole-genome and targeted sequencing of drug-resistant Mycobacterium tuberculosis on the iSeq100 and MiSeq: A performance, ease-of-use, and cost evaluation. PLoS Medicine. 16(4). e1002794–e1002794. 55 indexed citations

18.

Seifert, Marva, et al.. (2017). Performance of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis and rifampin resistance in a low-incidence, high-resource setting. PLoS ONE. 12(10). e0186139–e0186139. 34 indexed citations

19.

Seifert, Marva, Donald G. Catanzaro, Antonino Catanzaro, & Timothy C. Rodwell. (2015). Genetic Mutations Associated with Isoniazid Resistance in Mycobacterium tuberculosis: A Systematic Review. PLoS ONE. 10(3). e0119628–e0119628. 232 indexed citations

20.

Catanzaro, Antonino, Timothy C. Rodwell, Donald G. Catanzaro, et al.. (2015). Performance Comparison of Three Rapid Tests for the Diagnosis of Drug-Resistant Tuberculosis. PLoS ONE. 10(8). e0136861–e0136861. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact